<DOC>
	<DOCNO>NCT02219113</DOCNO>
	<brief_summary>Autologous adipose-derived regenerative cell ( ADRC ) extract use Celution 800/CRS System ( Cytori Therapeutics Inc ) portion fat harvest patient 's front abdominal wall . ADRC administer one-time intraarticularly . This single arm study control . All patient receive cell therapy .</brief_summary>
	<brief_title>Effectiveness Safety Autologous ADRC Treatment Degenerative Damage Knee Articular Cartilage</brief_title>
	<detailed_description>Patients verify diagnosis knee joint osteoarthritis ( degenerative damage knee articular cartilage ) undergo knee arthroscopic debridement . 28 day later patient undergo liposuction front abdominal wall local anesthesia . After autologous ADRC extract use Celution 800/CRS System ( Cytori Therapeutics Inc ) harvest adipose tissue . Extracted ADRC administer one-time intraarticularly .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Pain knee joint half day assess VAS ( score 40 mm ) At least three follow 6 criterion : 50 year age old , stiffness last less 30 minute , crepitus , bony tenderness , bony enlargement , warmth touch Patient able walk without assistance Patient familiar Participant information sheet Patient sign informed consent form Noninclusion Criteria : Medical history endoprosthetic knee replacement Medical history low extremity osteotomy Medical history knee surgery ( include arthroscopy ) precede 1 year prior enrollment Medical history intraarticular injection precede 6 month prior enrollment Secondary osteoarthritis knee joint : posttraumatic osteoarthritis ( develop clinically significant injury ) , intraarticular fracture , clinically significant varus valgus deformity low limb , septic arthritis , joint 's inflammatory disorder , gout , advanced chondrocalcinosis , Paget 's disease , ochronosis , acromegaly , hemochromatosis , Wilson 's disease , primary synovial osteochondromatosis , osteonecrosis , hemophilia Patients prescribed immunosuppressive treatment Medical history systemic autoimmune inflammatory diseases Significant weight loss ( &gt; 10 % body weight previous year ) unknown etiology Medical history venous thromboembolism estimate high risk venous thromboembolism Patients prescribed systemic corticosteroid medication treatment proven impact bone cartilage tissue metabolism Clinically significant abnormality result laboratory test Any condition limit compliance ( dementia , neuropsychiatric disease , drug alcohol abuse etc . ) Participation clinical trial ( administration investigational drug ) 3 month prior inclusion Patients malignant tumor include postoperative period , patient receive chemotherapy and/or radiotherapy . Patient 's activate partial thromboplastin time exceed normal level 1,8 time Patients prescribed anticoagulant treatment patient receive anticoagulant least one hour prior lipoaspiration Medical history heterotopic ossification Patients prescribed glycoprotein inhibitor treatment Patient 's refusal participation trial Patient 's refusal compliance requirement contraception participation research Chronic kidney disease IV V stage ( creatinine clearance &lt; 30 mL/min estimate CockroftGault formula ) Confirmed syphilis , HIV , hepatitis B C infection Dropout Criteria : Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Damage articular cartilage</keyword>
	<keyword>Cartilage degeneration</keyword>
	<keyword>Intraarticular injection</keyword>
	<keyword>ADRC</keyword>
	<keyword>Adipose-derived regenerative cell</keyword>
	<keyword>Adipose tissue</keyword>
	<keyword>Stem cell</keyword>
</DOC>